Massachusetts Financial Services CO Prelude Therapeutics Inc Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 549,530 shares of PRLD stock, worth $527,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares

549,530

Previous 522,375 5.2%

Holding current value

$527,548

Previous $1.99 Million 42.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.07 - $6.37 $56,210 - $172,977	27,155 Added 5.2%	549,530 $1.14 Million
Q2 2024 Aug 09, 2024	BUY	$3.32 - $5.63 $47,230 - $80,092	14,226 Added 2.8%	522,375 $1.99 Million
Q1 2024 May 14, 2024	SELL	$2.68 - $4.84 $6,968 - $12,584	-2,600 Reduced 0.51%	508,149 $2.41 Million
Q4 2023 Feb 08, 2024	BUY	$1.69 - $4.37 $794 - $2,053	470 Added 0.09%	510,749 $2.18 Million
Q3 2023 Nov 08, 2023	BUY	$2.74 - $4.79 $2,435 - $4,258	889 Added 0.17%	510,279 $1.58 Million
Q2 2023 Aug 09, 2023	SELL	$4.45 - $8.12 $22,953 - $41,882	-5,158 Reduced 1.0%	509,390 $2.29 Million
Q1 2023 May 10, 2023	SELL	$4.58 - $7.34 $1,937 - $3,104	-423 Reduced 0.08%	514,548 $2.93 Million
Q4 2022 Feb 13, 2023	BUY	$4.61 - $8.5 $7,735 - $14,263	1,678 Added 0.33%	514,971 $3.11 Million
Q3 2022 Nov 09, 2022	BUY	$5.0 - $8.82 $173,840 - $306,653	34,768 Added 7.27%	513,293 $3.39 Million
Q2 2022 Aug 09, 2022	SELL	$4.0 - $7.55 $14,376 - $27,134	-3,594 Reduced 0.75%	478,525 $2.5 Million
Q1 2022 May 11, 2022	BUY	$6.9 - $13.22 $91,921 - $176,116	13,322 Added 2.84%	482,119 $3.33 Million
Q4 2021 Feb 10, 2022	SELL	$11.89 - $31.74 $41,008 - $109,471	-3,449 Reduced 0.73%	468,797 $5.84 Million
Q3 2021 Nov 10, 2021	BUY	$25.78 - $38.65 $2.5 Million - $3.75 Million	97,080 Added 25.88%	472,246 $14.8 Million
Q2 2021 Aug 13, 2021	BUY	$28.63 - $44.3 $2.69 Million - $4.16 Million	94,002 Added 33.43%	375,166 $10.7 Million
Q1 2021 May 13, 2021	SELL	$39.27 - $91.68 $118,713 - $277,148	-3,023 Reduced 1.06%	281,164 $12.2 Million
Q4 2020 Feb 12, 2021	SELL	$28.81 - $88.94 $6.74 Million - $20.8 Million	-233,824 Reduced 45.14%	284,187 $20.3 Million
Q3 2020 Nov 12, 2020	BUY	$26.2 - $30.13 $13.6 Million - $15.6 Million	518,011 New	518,011 $15.6 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

35.7M

Call Options Held

500

Put Options Held

300

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.9M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Prelude Therapeutics Inc Transaction History